Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of VLS-101 in Patients With Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04504916
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:59.100645+00:00
Published At
2024-08-15T00:00:00+00:00
Record Updated At
2025-11-10
Results Posted At
2024-08-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Triple-negative Breast Cancer", "Non-squamous Non-small-cell Lung Cancer", "NSCLC", "Estrogen-receptor-positive Breast Cancer", "Progesterone-receptor-positive Breast Cancer", "Estrogen-receptor-negative Breast Cancer", "ER-negative Breast Cancer", "Progesterone-receptor Negative Breast Cancer", "PR-negative Breast Cancer", "HER2-negative Breast Cancer", "ER-positive Breast Cancer", "PR-positive Breast Cancer", "Platinum-resistant Ovarian Cancer", "Gastric Cancer", "Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-10"
protocolSection.identificationModule.nctId
"NCT04504916"
protocolSection.identificationModule.officialTitle
"A Phase 2 Study of VLS-101 in Patients With Solid Tumors"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-08-15"

Study condition terms

  • Triple-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Non-squamous Non-small-cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • NSCLC (protocolSection.conditionsModule.conditions)
  • Estrogen-receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Progesterone-receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Estrogen-receptor-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • ER-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Progesterone-receptor Negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • PR-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • HER2-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • ER-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • PR-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Platinum-resistant Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.